Report Detail
Global GLP-1RA Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
- RnM4540692 |
- 19 July, 2023 |
- Global |
- 97 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global GLP-1RA Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global GLP-1RA Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global GLP-1RA Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global GLP-1RA Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global GLP-1RA Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global GLP-1RA Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for GLP-1RA Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace.
This report profiles key players in the global GLP-1RA Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Eli Lilly And Company, AstraZeneca, Merck and Innovent Biologics and etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
GLP-1RA Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Oral Tablets
Injection
Market segment by Application
Hypoglycemia
Weight Loss
Other
Major players covered
Novo Nordisk
Eli Lilly And Company
AstraZeneca
Merck
Innovent Biologics
Daoer Bio
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe GLP-1RA Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of GLP-1RA Drugs, with price, sales, revenue and global market share of GLP-1RA Drugs from 2018 to 2023.
Chapter 3, the GLP-1RA Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the GLP-1RA Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and GLP-1RA Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of GLP-1RA Drugs.
Chapter 14 and 15, to describe GLP-1RA Drugs sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of GLP-1RA Drugs
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global GLP-1RA Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Oral Tablets
- 1.3.3 Injection
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global GLP-1RA Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Hypoglycemia
- 1.4.3 Weight Loss
- 1.4.4 Other
- 1.5 Global GLP-1RA Drugs Market Size & Forecast
- 1.5.1 Global GLP-1RA Drugs Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global GLP-1RA Drugs Sales Quantity (2018-2029)
- 1.5.3 Global GLP-1RA Drugs Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 Novo Nordisk
- 2.1.1 Novo Nordisk Details
- 2.1.2 Novo Nordisk Major Business
- 2.1.3 Novo Nordisk GLP-1RA Drugs Product and Services
- 2.1.4 Novo Nordisk GLP-1RA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Novo Nordisk Recent Developments/Updates
- 2.2 Eli Lilly And Company
- 2.2.1 Eli Lilly And Company Details
- 2.2.2 Eli Lilly And Company Major Business
- 2.2.3 Eli Lilly And Company GLP-1RA Drugs Product and Services
- 2.2.4 Eli Lilly And Company GLP-1RA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Eli Lilly And Company Recent Developments/Updates
- 2.3 AstraZeneca
- 2.3.1 AstraZeneca Details
- 2.3.2 AstraZeneca Major Business
- 2.3.3 AstraZeneca GLP-1RA Drugs Product and Services
- 2.3.4 AstraZeneca GLP-1RA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 AstraZeneca Recent Developments/Updates
- 2.4 Merck
- 2.4.1 Merck Details
- 2.4.2 Merck Major Business
- 2.4.3 Merck GLP-1RA Drugs Product and Services
- 2.4.4 Merck GLP-1RA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Merck Recent Developments/Updates
- 2.5 Innovent Biologics
- 2.5.1 Innovent Biologics Details
- 2.5.2 Innovent Biologics Major Business
- 2.5.3 Innovent Biologics GLP-1RA Drugs Product and Services
- 2.5.4 Innovent Biologics GLP-1RA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Innovent Biologics Recent Developments/Updates
- 2.6 Daoer Bio
- 2.6.1 Daoer Bio Details
- 2.6.2 Daoer Bio Major Business
- 2.6.3 Daoer Bio GLP-1RA Drugs Product and Services
- 2.6.4 Daoer Bio GLP-1RA Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Daoer Bio Recent Developments/Updates
3 Competitive Environment: GLP-1RA Drugs by Manufacturer
- 3.1 Global GLP-1RA Drugs Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global GLP-1RA Drugs Revenue by Manufacturer (2018-2023)
- 3.3 Global GLP-1RA Drugs Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of GLP-1RA Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 GLP-1RA Drugs Manufacturer Market Share in 2022
- 3.4.2 Top 6 GLP-1RA Drugs Manufacturer Market Share in 2022
- 3.5 GLP-1RA Drugs Market: Overall Company Footprint Analysis
- 3.5.1 GLP-1RA Drugs Market: Region Footprint
- 3.5.2 GLP-1RA Drugs Market: Company Product Type Footprint
- 3.5.3 GLP-1RA Drugs Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global GLP-1RA Drugs Market Size by Region
- 4.1.1 Global GLP-1RA Drugs Sales Quantity by Region (2018-2029)
- 4.1.2 Global GLP-1RA Drugs Consumption Value by Region (2018-2029)
- 4.1.3 Global GLP-1RA Drugs Average Price by Region (2018-2029)
- 4.2 North America GLP-1RA Drugs Consumption Value (2018-2029)
- 4.3 Europe GLP-1RA Drugs Consumption Value (2018-2029)
- 4.4 Asia-Pacific GLP-1RA Drugs Consumption Value (2018-2029)
- 4.5 South America GLP-1RA Drugs Consumption Value (2018-2029)
- 4.6 Middle East and Africa GLP-1RA Drugs Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global GLP-1RA Drugs Sales Quantity by Type (2018-2029)
- 5.2 Global GLP-1RA Drugs Consumption Value by Type (2018-2029)
- 5.3 Global GLP-1RA Drugs Average Price by Type (2018-2029)
6 Market Segment by Application
- 6.1 Global GLP-1RA Drugs Sales Quantity by Application (2018-2029)
- 6.2 Global GLP-1RA Drugs Consumption Value by Application (2018-2029)
- 6.3 Global GLP-1RA Drugs Average Price by Application (2018-2029)
7 North America
- 7.1 North America GLP-1RA Drugs Sales Quantity by Type (2018-2029)
- 7.2 North America GLP-1RA Drugs Sales Quantity by Application (2018-2029)
- 7.3 North America GLP-1RA Drugs Market Size by Country
- 7.3.1 North America GLP-1RA Drugs Sales Quantity by Country (2018-2029)
- 7.3.2 North America GLP-1RA Drugs Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe GLP-1RA Drugs Sales Quantity by Type (2018-2029)
- 8.2 Europe GLP-1RA Drugs Sales Quantity by Application (2018-2029)
- 8.3 Europe GLP-1RA Drugs Market Size by Country
- 8.3.1 Europe GLP-1RA Drugs Sales Quantity by Country (2018-2029)
- 8.3.2 Europe GLP-1RA Drugs Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific GLP-1RA Drugs Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific GLP-1RA Drugs Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific GLP-1RA Drugs Market Size by Region
- 9.3.1 Asia-Pacific GLP-1RA Drugs Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific GLP-1RA Drugs Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America GLP-1RA Drugs Sales Quantity by Type (2018-2029)
- 10.2 South America GLP-1RA Drugs Sales Quantity by Application (2018-2029)
- 10.3 South America GLP-1RA Drugs Market Size by Country
- 10.3.1 South America GLP-1RA Drugs Sales Quantity by Country (2018-2029)
- 10.3.2 South America GLP-1RA Drugs Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa GLP-1RA Drugs Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa GLP-1RA Drugs Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa GLP-1RA Drugs Market Size by Country
- 11.3.1 Middle East & Africa GLP-1RA Drugs Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa GLP-1RA Drugs Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 GLP-1RA Drugs Market Drivers
- 12.2 GLP-1RA Drugs Market Restraints
- 12.3 GLP-1RA Drugs Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 12.5 Influence of COVID-19 and Russia-Ukraine War
- 12.5.1 Influence of COVID-19
- 12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
- 13.1 Raw Material of GLP-1RA Drugs and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of GLP-1RA Drugs
- 13.3 GLP-1RA Drugs Production Process
- 13.4 GLP-1RA Drugs Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 GLP-1RA Drugs Typical Distributors
- 14.3 GLP-1RA Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on GLP-1RA Drugs. Industry analysis & Market Report on GLP-1RA Drugs is a syndicated market report, published as Global GLP-1RA Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of GLP-1RA Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
